Literature DB >> 9665150

Identification of a possible somatic BRCA1 mutation affecting translation efficiency in an early-onset sporadic breast cancer patient.

S Papa, D Seripa, G Merla, C Gravina, M Giai, P Sismondi, M Rinaldi, A Serra, G Saglio, V M Fazio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9665150     DOI： 10.1093/jnci/90.13.1011

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.

Authors:  H Ruffner; W Jiang; A G Craig; T Hunter; I M Verma
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  Decreased expression of BRCA1 in SK-BR-3 cells is the result of aberrant activation of the GABP Beta promoter by an NRF-1-containing complex.

Authors:  Crista Thompson; Gwen MacDonald; Christopher R Mueller
Journal:  Mol Cancer       Date:  2011-05-24       Impact factor: 27.401

3.  Characterization of a negative transcriptional element in the BRCA1 promoter.

Authors:  Gwen MacDonald; Melissa Stramwasser; Christopher R Mueller
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

Review 4.  Regulation of BRCA1 expression and its relationship to sporadic breast cancer.

Authors:  Christopher R Mueller; Calvin D Roskelley
Journal:  Breast Cancer Res       Date:  2002-11-13       Impact factor: 6.466

5.  Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade.

Authors:  S L Ding; L F Sheu; J C Yu; T L Yang; B F Chen; F J Leu; C Y Shen
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.